BOULDER, Colo.--(BUSINESS WIRE)-- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and full year of fiscal 2011 on Monday, August 8, 2011, and will hold a conference call on Tuesday, August 9, 2011 at 9:00 a.m. eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.
|
Conference Call Information |
||
|
Date: |
Tuesday, August 9, 2011 | |
|
Time: |
9:00 a.m. eastern time | |
|
Toll-Free: |
866-202-4367 | |
|
Toll: |
617-213-8845 | |
|
Pass Code: |
26152637 | |
|
Webcast & Conference Call Slides: http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome |
||
A replay of the call will be available as a webcast on www.arraybiopharma.com.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to www.arraybiopharma.com.
CONTACT:
Array BioPharma Inc.
Tricia Haugeto
303-386-1193
[email protected]
KEYWORDS: United States North America Colorado
INDUSTRY KEYWORDS: Health Biotechnology Clinical Trials Infectious Diseases Oncology Pharmaceutical
MEDIA: